Voice Analysis for Monitoring Patients With Heart Failure
Recruiting · NCT06566911 · Observational (researchers observe without assigning treatment) · Lead sponsor: Noah Labs
View the official record on ClinicalTrials.gov →What this trial is about
This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.
Who can take part
Inclusion criteria
- Clinically diagnosed with Acutely Decompensated Heart Failure.
- At least 18 years of age.
Exclusion criteria
- Disabling mental diseases (e.g., Alzheimer's disease)
- Clinically diagnosed chronic obstructive pulmonary disease (COPD)
- Treatment in ICU or IMU
- Dialysis treatment
- Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.)
- Neurodegenerative diseases
- Pregnancy
- Inability to provide consent
Where it is running
2 locations listed across 1 US state.
- Mayo Clinic - Rochester, Minnesota, United States
- Deutsches Herzzentrum der Charité - Berlin, Germany